Podcasts about Chronic obstructive pulmonary disease

A study of almost 250.000 people found people who vape had a far higher risk of getting Chronic Obstructive Pulmonary Disease, a serious, incurable disease that makes breathing difficult. Asthma and Respiratory Foundation NZ Chief Executive Letitia Harding spoke to Ingrid Hipkiss.

This episode is sponsored by https://WE-PN.com Become your own VPN provider.To get 50% off enter promo code: kingraam50-------------------------This episode is sponsored by BetterHelp. Give online therapy a try at https://betterhelp.com/MASTYORASTY and get on your way to being your best self.-------------------------Ramtin Bidares is a geneticist and researcher on Epigenetic Modifications and Therapy in Chronic Obstructive Pulmonary Disease in Sapienza University of Rome. This is part of the evolution of man. This is part 2 of our conversation. You can listen to part one over here:https://youtu.be/YdAgILn_ONkhttps://www.instagram.com/ramtinbidares/-------------------------To learn more about psychedelic therapy go to my brother Mehran's page at: https://www.mindbodyintegration.ca/ or to https://www.somaretreats.org for his next retreat.***Masty o Rasty is not responsible for, or condone, the views and opinions expressed by our guests ******مستی و راستی هیچگونه مسولیتی در برابر نظرها و عقاید مهمان‌های برنامه ندارد.***--------Support the showhttps://paypal.me/raamemamiVenmo + Revolut: @KingRaam Hosted on Acast. See acast.com/privacy for more information.

Dhineli Perera speaks with Lee Fong, a medical advisor for the Australian Commission on Safety and Quality in Health Care, about the need to establish a national clinical care standard for people with chronic obstructive pulmonary disease (COPD). Lee explains how the Standard can be used to identify gaps in care and optimise the management of patients with COPD. Read the full article by Lee and his co-authors in Australian Prescriber.

Ramtin Bidares is a geneticist and researcher on Epigenetic Modifications and Therapy in Chronic Obstructive Pulmonary Disease in Sapienza University of Rome. In this episode Ramtin explains the story of how we evolved into becoming humans. This is part of this series on evolution. https://www.instagram.com/ramtinbidares/-------------------------To learn more about psychedelic therapy go to my brother Mehran's page at: https://www.mindbodyintegration.ca/ or to https://www.somaretreats.org/ for his next retreat.***Masty o Rasty is not responsible for, or condone, the views and opinions expressed by our guests ******مستی و راستی هیچگونه مسولیتی در برابر نظرها و عقاید مهمان‌های برنامه ندارد.***--------Support the showhttps://paypal.me/raamemamiVenmo + Revolut: @KingRaam Hosted on Acast. See acast.com/privacy for more information.

Listener discretion is advised (language). References: Abdo WF, Heunks LM. Oxygen-induced hypercapnia in COPD: myths and facts. Crit Care. 2012 Oct 29;16(5):323. Bonilla Arcos D, Krishnan JA, et al. High-Dose Versus Low-Dose Systemic Steroids in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Systematic Review. Chronic Obstr Pulm Dis. 2016 Feb 17;3(2):580-588. Fawzy A, Wise RA. Pulse Oximetry Misclassifies Need for Long-Term Oxygen Therapy in Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2023 Nov;20(11):1556-1557. Goldberg P, Reissmann H, Maltais F, Ranieri M, Gottfried SB. Efficacy of noninvasive CPAP in COPD with acute respiratory failure. Eur Respir J. 1995 Nov;8(11):1894-900. Jennifer T. Thibodeau, Mark H. Drazner. The Role of the Clinical Examination in Patients With Heart Failure,JACC: Heart Failure, Volume 6, Issue 7, 2018, Pages 543-551. Kartal M, Goksu E, Eray O, et al. The value of ETCO2 measurement for COPD patients in the emergency department. Eur J Emerg Med. 2011 Feb;18(1):9-12. Ni, H., Aye, S., Naing, C. Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2022 May 26; 2022(5):CD013506. Pertzov, B., Ronen, M., Rosengarten, D. et al. Use of capnography for prediction of obstruction severity in non-intubated COPD and asthma patients. Respir Res 22, 154 (2021). Pu X, Liu L, Feng B, Wang M, Dong L, Zhang Z, Fan Q, Li Y, Wang G. Efficacy and Safety of Different Doses of Systemic Corticosteroids in COPD Exacerbation. Respir Care. 2021 Feb;66(2):316-326. Tyagi D, Govindagoudar MB, et al. Correlation of PaCO2 and ETCO2 in COPD Patients with Exacerbation on Mechanical Ventilation. Indian J Crit Care Med. 2021 Mar;25(3):305-309. van Gestel AJ, Steier J. Autonomic dysfunction in patients with chronic obstructive pulmonary disease (COPD). J Thorac Dis. 2010 Dec;2(4):215-22. doi: 10.3978/j.issn.2072-1439.2010.02.04.5.

Laura Beaton chats with Debbie Rigby, from the National Asthma Council, about her paper on inhaler device selection for people with asthma or chronic obstructive pulmonary disease. Debbie outlines the different types of inhalers available, and explains their benefits, limitations and environmental considerations. They also discuss ensuring patients are using their inhalers effectively. Read the full article by Debbie in Australian Prescriber.

Join us as we raise awareness for those living with Chronic Obstructive Pulmonary Disease. Our latest podcast features Chris Barron, respiratory nurse specialist who looks further into COPD management, tips for better lung health and the latest treatments making a difference.Whether you're living with COPD, caring for some with the disease or just want to learn more, tune in here. #WorldCOPDDay #COPD #LungHealth

This week Bobbi Conner talks with MUSC's Dr. Charlie Strange about the diagnosis and treatment of COPD.

Long-acting muscarinic antagonist and long-acting β2-agonist combination for the treatment of maintenance therapy–naïve patients with chronic obstructive pulmonary disease: a narrative review

Dr. Dolin on chronic obstructive pulmonary disease & asthma.

Dr. Wright shares insights into her transition to leading a major non-profit dedicated to improving the lives of those with COPD and other lung diseases. From predictive analytics to advocacy and awareness, discover how her visionary leadership is shaping the future of chronic disease management. Timestamps:   (00:00) -Introduction (03:16) -Jean's journey from paediatrics and anaesthesia to becoming the CEO of the COPD Foundation (05:56) -How Jean's transformative approaches influenced her current role at the COPD foundation (09:40) -Jean's work looking at prevalence of COPD along the gorgeous Appalachians in America (21:00) -Diagnosis rates of COPD in the US (24:50) -If we diagnose COPD early, what can we do about it? (27:51) -The need for investment in research (31:00) -The vaping epidemic (33:00) -Ways to improve our lung health (36:30) -Reasons why women have twice the burden of COPD (40:34) -Celebrity awareness campaign for this disease (43:03) -Jean's three magic wishes

In this episode, Steve Roest, CEO of PocDoc and host of the HealthTech Hour speaks to Paul McGinness the Co-Founder and CEO of Lenus Health - focused on delivering predictive AI to transform the diagnosis and treatment of chronic conditions. COPD, or Chronic Obstructive Pulmonary Disease, is the second highest cause of A&E visits, is a chronic condition that worsens over time. The prevalence and severity of this disease is worsening. Paul has spent the last 20 years bootstrapping his own technology empire and now is focused on applying his amazing experience to Health - and the area of remote patient monitoring. AI is going to revolutionise this space....but it needs to be done right, safely without stopping the amazing impact it could have.

Thank you for listening to this episode of "Health and Fitness" from the Nezpod Studios! Enjoy your night or the start of your day, spiced by our top-notch health and fitness/wellness updates coined from the best sources around the globe: made only for your utmost enjoyment and enlightenment… Click on subscribe to get more spicy episodes for free! See you again soon on the next episode of Health and Fitness Updates! Learn more about your ad choices. Visit megaphone.fm/adchoices

Thank you for listening to this episode of "Health and Fitness" from the Nezpod Studios! Enjoy your night or the start of your day, spiced by our top-notch health and fitness/wellness updates coined from the best sources around the globe: made only for your utmost enjoyment and enlightenment… Click on subscribe to get more spicy episodes for free! See you again soon on the next episode of Health and Fitness Updates! Learn more about your ad choices. Visit megaphone.fm/adchoices

Thank you for listening to this episode of "Health and Fitness" from the Nezpod Studios! Enjoy your night or the start of your day, spiced by our top-notch health and fitness/wellness updates coined from the best sources around the globe: made only for your utmost enjoyment and enlightenment… Click on subscribe to get more spicy episodes for free! See you again soon on the next episode of Health and Fitness Updates! Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode 33! In this episode we are excited to be joined by Eddy Fan and Whitney Gannon, two extraordinary ECMO researchers to talk about VENT-AVOID or " Extracorporeal Carbon Dioxide Removal to Avoid Invasive Ventilation During Exacerbations of Chronic Obstructive Pulmonary Disease" published March 2024 by Duggal et al in the ATS Blue Journal.VENT-AVOID: https://pubmed.ncbi.nlm.nih.gov/38261630/If you enjoy the show be sure to like and subscribe, leave that 5 star review! Be sure to follow us on the social @icucast for the associated figures, comments, and other content not available in the audio format! Email us at icuedandtoddcast@gmail.com with any questions or suggestions! Thank you Mike Gannon for the intro and exit music!

Please visit answersincme.com/TXC860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in pulmonology discusses the unmet therapeutic needs in patients with chronic obstructive pulmonary disease (COPD) and the rationale for targeting Type 2 inflammation. Upon completion of this activity, participants should be better able to: Recognize the unmet therapeutic needs in patients with COPD; Identify patients with COPD who are at high risk of exacerbations despite receiving standard therapies; and Recognize the rationale for targeting Type 2 inflammation for the treatment of COPD.

Please visit answersincme.com/TXC860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in pulmonology discusses the unmet therapeutic needs in patients with chronic obstructive pulmonary disease (COPD) and the rationale for targeting Type 2 inflammation. Upon completion of this activity, participants should be better able to: Recognize the unmet therapeutic needs in patients with COPD; Identify patients with COPD who are at high risk of exacerbations despite receiving standard therapies; and Recognize the rationale for targeting Type 2 inflammation for the treatment of COPD.

Cystic Fibrosis explained, including Cystic Fibrosis pathophysiology, as well as its common symptoms. We also cover how Cystic Fibrosis is diagnosed (including newborn screening,  sweat testing and genetic testing) as well as Cystic Fibrosis treatment (with CFTR modulators!). Consider subscribing on YouTube (if you found any of the info useful!): https://www.youtube.com/channel/UCRks8wB6vgz0E7buP0L_5RQ?sub_confirmation=1Patreon: https://www.patreon.com/rhesusmedicineBuy Us A Coffee!: https://www.buymeacoffee.com/rhesusmedicineTimestamps: 0:00 What is Cystic Fibrosis?0:53 Cystic Fibrosis Pathophysiology5:55 Cystic Fibrosis Symptoms 7:19 Cystic Fibrosis Diagnosis9:29 Cystic Fibrosis TreatmentReferencesBMJ Best Practice (2023) Cystic Fibrosis. Available at https://bestpractice.bmj.com/topics/en-gb/403MSD Manuals Pro (2022) Cystic Fibrosis. Available at https://www.msdmanuals.com/professional/pediatrics/cystic-fibrosis-cf/cystic-fibrosisFenker, D (2018) A Comparison between Two Pathophysiologically Different yet Microbiologically Similar Lung Diseases: Cystic Fibrosis and Chronic Obstructive Pulmonary Disease. Available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322854/Cystic Fibrosis Trust (2022) UK Cystic Fibrosis Registry 2021 Annual Data Report. Available at https://www.cysticfibrosis.org.uk/news/key-findings-from-the-2021-cf-registry-reportElaine Yu; Sandeep Sharma (2022) Cystic Fibrosis. Available at https://www.ncbi.nlm.nih.gov/books/NBK493206/British Lung Foundation. Cystic Fibrosis statistics. Available at https://statistics.blf.org.uk/cystic-fibrosisAndrea H. Roe (2021) Gynecologic health care for females with cystic fibrosis.        Available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607192/Please remember this podcast and all content from Rhesus Medicine is meant for educational purposes only and should not be used as a guide to diagnose or to treat. Please consult a healthcare professional for medical advice. 

Chronic Obstructive Pulmonary Disease (COPD) explained, including COPD pathophysiology, signs and symptoms, COPD diagnosis and treatment (with GOLD recommendations). Consider subscribing on YouTube (if you found any of the info useful!): https://www.youtube.com/channel/UCRks8wB6vgz0E7buP0L_5RQ?sub_confirmation=1Patreon: https://www.patreon.com/rhesusmedicineBuy Us A Coffee!: https://www.buymeacoffee.com/rhesusmedicineTimestamps:0:00 What is Chronic Obstructive Pulmonary Disease (COPD)? 0:20 Normal Anatomy & Breathing Physiology1:06 COPD Pathophysiology 3:20 COPD Causes3:56 COPD Symptoms6:08 COPD Exacerbations & Complications6:52 COPD Diagnosis8:58 COPD Treatment - Exacerbation9:52 COPD Treatment - Stable ReferencesMSD Manuals Pro (2022) Chronic Obstructive Pulmonary Disease (COPD). Available at https://www.msdmanuals.com/professional/pulmonary-disorders/chronic-obstructive-pulmonary-disease-and-related-disorders/chronic-obstructive-pulmonary-disease-copdBMJ Best Practice (2023) Chronic obstructive pulmonary disease (COPD). Available at https://bestpractice.bmj.com/topics/en-gb/7/Pandirajan, K. - TeachMePhysiology (2023) Mechanics of Breathing. Available at https://teachmephysiology.com/respiratory-system/ventilation/mechanics-of-breathing/Anuj K. Agarwal (2023) Chronic Obstructive Pulmonary Disease. ****Available at https://www.ncbi.nlm.nih.gov/books/NBK559281/Global Initiative for Chronic Obstructive Lung Disease (2023). 2023 GOLD REPORT. Available at https://goldcopd.org/2023-gold-report-2/Please remember this podcast and all content from Rhesus Medicine is meant for educational purposes only and should not be used as a guide to diagnose or to treat. Please consult a healthcare professional for medical advice. 

In this episode, Rick Zimmerman, MD, MPH, FAAFP, discusses RSV vaccines in older adults, including: Breakthroughs in RSV vaccine developmentRSV vaccine snapshot in older adultsFDA-approved RSV vaccines for older adultsCDC evidence to recommendations framework for vaccinesRSV burden in older populationsBenefits and harms of RSV vaccinationRSV vaccine efficacy and safety in older adultsCDC Advisory Committee Immunization Practices recommendations for RSV vaccines in older adultsPopulations at high risk for severe RSV diseaseVaccination considerations based on the upcoming RSV seasonFaculty:Richard Zimmerman, MD, MPH, FAAFPProfessorDepartment of Family Medicine and Clinical Epidemiology  University of PittsburghPittsburgh, PennsylvaniaContent based on an online CME program supported by an independent educational grant from GlaxoSmithKline.Link to full program: https://bit.ly/49YBZ4rLink to downloadable slides: https://bit.ly/3GocjRe

In this episode, Angela Branche, MD; Pamela Rockwell, DO, FAAFP; and Richard Zimmerman, MD, MPH, FAAFP, discuss the clinical presentation of RSV in older adults and available diagnostic tests for RSV, including: Comparison of RSV clinical symptoms to influenza and COVID-19, including differentiating symptoms at infection onsetRSV disease progression RSV diagnostic approaches How RSV diagnosis of adults may differ from diagnosis of childrenClinical considerations for RSV testingHow to improve RSV awareness among patientsProgram Director:Pamela Rockwell, DO, FAAFPProfessorFamily MedicineUniversity of Michigan Medical SchoolAnn Arbor, MichiganFaculty:Angela Branche, MDAssociate Professor of MedicineDivision of Infectious DiseasesDepartment of MedicineUniversity of RochesterRochester, New YorkRichard Zimmerman, MD, MPH, FAAFPProfessorDepartment of Family Medicine and Clinical Epidemiology University of PittsburghPittsburgh, PennsylvaniaContent based on an online CME program supported by an independent educational grant from GlaxoSmithKline.Link to full program:https://bit.ly/49YBZ4rLink to downloadable slides: https://bit.ly/3GocjRe

In this episode, Angela Branche, MD; Pamela Rockwell, DO, FAAFP; and Rick Zimmerman, MD, MPH, FAAFP, discuss the burden of RSV in older adults, including:RSV burden throughout lifeRSV seasonality in the United StatesComparative burden and incidence of RSV and influenza in adults aged 65 years or olderCardiopulmonary hospitalizations of long-term care facility residents with influenza and/or RSVRisk factors for severe RSV (eg, hospitalization, mortality) in older adultsRSV incidence by presence of underlying medical conditionsRSV awareness among healthcare professionals and patients Program Director:Pamela Rockwell, DO, FAAFPProfessorFamily MedicineUniversity of Michigan Medical SchoolAnn Arbor, MichiganFaculty:Angela Branche, MDAssociate Professor of MedicineDivision of Infectious DiseasesDepartment of MedicineUniversity of RochesterRochester, New YorkRichard Zimmerman, MD, MPH, FAAFPProfessorDepartment of Family Medicine and Clinical Epidemiology  University of PittsburghPittsburgh, PennsylvaniaContent based on an online CME program supported by an independent educational grant from GlaxoSmithKline.Link to full program: https://bit.ly/49YBZ4rLink to downloadable slides: https://bit.ly/3GocjRe 

Chronic Obstructive Pulmonary Disease, or COPD, is a disease that affects hundreds of thousands of New Zealanders. The Asthma and Respiratory Foundation New Zealand has released a patient handbook, which includes information about patient conditions, and recommendations for COPD treatments and managements.  Olivia spoke to Asthma and Respiratory Foundation NZ's Education and Development Manager, Joanna Turner, about what COPD is, and steps people can take to prevent and mitigate it.

Clare's Chronic Obstructive Pulmonary Disease group chairperson believes air quality problems 'fly under the radar' The Environmental Protection Agency last week launched the new national air quality forecast service which will provide two updated daily forecasts about how healthy the air is for breathing and the level of key pollutants in each block. Clare County Council received 25 air pollution complaints in 2022 with this type of pollution in the county linked to 47 premature deaths in the same timeframe. Clare COPD chairperson, James Gallagher, is welcoming the launch of the service.

KYW Newsradio's Rasa Kaye continues her discussion with Deborah Heart and Lung Center's pulmonologist Howard Waksman, MD. Listen to Part 2 to learn the signs of early detection of chronic obstructive pulmonary disease.

Live Nursing Review with Regina MSN, RN! Every Monday & Wednesday we are live. LIKE, FOLLOW, & SUB @ReMarNurse for more.     Sign up for the NCLEX 30-Day Challenge Review now at http://www.ReMarNurse.com/30Days   Quick Facts for NCLEX Next Gen Study Guide here - https://bit.ly/QF-NGN Study with Professor Regina MSN, RN every Monday as you prepare for NCLEX Next Gen.   ► Create Free V2 Account - http://www.ReMarNurse.com ► Get Quick Facts Next Gen - https://bit.ly/QF-NGN ► Subscribe Now - http://bit.ly/ReMar-Subscription ► GET THE PODCAST: https://remarnurse.podbean.com/ ► WATCH LESSONS: http://bit.ly/ReMarNCLEXLectures/ ► FOLLOW ReMar on Instagram: https://www.instagram.com/ReMarNurse/ ► LIKE ReMar on Facebook: https://www.facebook.com/ReMarReview/   ReMar Review features weekly NCLEX review questions and lectures from Regina M. Callion MSN, RN. ReMar is the #1 content-based NCLEX review and has helped thousands of repeat testers pass NCLEX with a 99.2% student success rate! ReMar focuses on 100% core nursing content and as a result, has the best review to help nursing students to pass boards - fast!

Dr. John Fleetham chats with Dr. Surya Bhatt about his article, “FEV1/FVC Severity Stages for Chronic Obstructive Pulmonary Disease.”

KYW Newsradio's Rasa Kaye discusses chronic obstructive pulmonary disease with Deborah Heart and Lung Center's pulmonologist Howard Waksman, MD. Listen to learn the signs of early detection.

Joining us on Well Said is Dr. Bushra Mina, Program Director of Pulmonary Critical Care Fellowship with Northwell Health and Associate Professor at the Donald and Barbara Zucker School of Medicine to discuss how Chronic Obstructive Pulmonary Disease, also known as “COPD” is believed to be largely underdiagnosed and, even still, has been linked to over 3.2 million deaths worldwide.

This episode covers COPD.Written notes can be found at https://zerotofinals.com/medicine/respiratory/copd/ or in the respiratory section of the 2nd edition of the Zero to Finals medicine book.The audio in the episode was expertly edited by Harry Watchman.

With inhaler prices soaring, patients find themselves grappling with a heartbreaking choice: compromised respiratory health or financial strain.

This podcast explores the burden of chronic inflammation for patients with chronic obstructive pulmonary disease (COPD) and its negative impact on quality of life. The following experts in the field review diagnosis, discussing what stage COPD is typically diagnosed at and how it presents differently to asthma, alongside further insights into patient perspective including what can be improved at the outset of diagnosis.  Guest Speakers: Claus Vogelmeier, Professor of Medicine and Head of the Department of Pneumology, University Hospital Marburg, Germany Nicola Hanania, Professor of Medicine and Section Chief of Pulmonary, Critical Care and Sleep Medicine, Ben Taub Hospital, Houston, Texas John Linnell, Patient Advocate The publication of this podcast was funded by Sanofi and Regeneron.

Editor's Summary by Anne Rentoumis Cappola, MD, ScM, Associate Editor of JAMA, the Journal of the American Medical Association, for the June 6, 2023, issue. Related Content: Audio Highlights

The McCullough Report with Dr. Peter McCullough – Dr. Robert Clancy stood with doctors across the world, calling for treatment of acute COVID-19 early in order to prevent invasive disease. Professor Clancy and his team's groundbreaking research into Chronic Obstructive Pulmonary Disease concentrated on the link between the gut and the lung...

The McCullough Report with Dr. Peter McCullough – Dr. Robert Clancy stood with doctors across the world, calling for treatment of acute COVID-19 early in order to prevent invasive disease. Professor Clancy and his team's groundbreaking research into Chronic Obstructive Pulmonary Disease concentrated on the link between the gut and the lung...

Chronic lung disease currently accounts for a large percentage of deaths in both males and females. This podcast challenges stereotypes and provides insights into the differences in respiratory care between sexes. Featured on this episode is Nicolas Roche, Professor of Respiratory Medicine, Paris Cité University, and the Department of Respiratory Medicine, Cochin Hospital, Paris, France. Roche gives an overview on chronic obstructive pulmonary disease (COPD), describing the leading causes and burden of this condition, and addressing gender differences and the perception that this is a predominantly male disease. Physical, social, and lifestyle differences are all considered in relation to common lung diseases such as asthma and bronchiectasis. Roche also uses his expertise to outline several important clinical considerations, including initiatives to combat underdiagnosis of COPD in females, and the steps that can be taken to improve disparities in respiratory care based on sex and gender. This content is sponsored by Philips.

In this episode, Angela Branche, MD, and Helen Y. Chu, MD, MPH, discuss the clinical presentation of respiratory syncytial virus (RSV) in adults and the importance of early detection, including:  Clinical symptoms and presentation  Complications, including exacerbations of cardiopulmonary diseasesUse of medical resources compared with other respiratory virusesDiagnostic approaches and challengesTreatment and management of RSV diseaseClinical impact of RSV awarenessFaculty:  Angela Branche, MDAssociate Professor of MedicineDivision of Infectious DiseasesDepartment of MedicineUniversity of RochesterRochester, New YorkHelen Y. Chu, MD, MPHAssociate Professor of MedicineDivision of Allergy & Infectious DiseasesUniversity of Washington  School of MedicineSeattle, WashingtonLink to full program: bit.ly/3nb25xeLink to downloadable slides:bit.ly/3TsXym5

When you have Chronic Obstructive Pulmonary Disease breathing can be a challenge. Hyperbaric Oxygen Therapy is one of the treatments for COPD that has benefits. However in certain situations HBOT might be contraindicated in patients with COPD, especially in the late stages of COPD. I explore benefits of HBOT for COPD and potential concerns and contraindications, providing insights and tips for those affected by COPD and their caregivers. Tune in now to learn more and make an informed decision on Hyperbaric Therapy and COPD. Timestamps: 00:00 INTRO 00:29 What is COPD? 1:55 What is HBOT 3:00 HBOT benefits in COPD 4:15 Contraindications for HBOT in COPD

The second in a two-part discussion regarding 2023 updates to the GOLD Guidelines for COPD. Drs. Kalhan and Ohar discuss what's new, what's changed, and what this means to those who see and care for patients with COPD.

What is COPD, and what can you do about it? Dr. Berg's Keto and IF Lab: https://www.facebook.com/groups/drbergslab/ How to Bulletproof your Immune System FREE Course: https://bit.ly/39Ry3s2 FREE MINI-COURSE ➜ ➜ Take Dr. Berg's Free Keto Mini-Course! ADD YOUR SUCCESS STORY HERE: https://bit.ly/3z9TviS Find Your Body Type: https://www.drberg.com/body-type-quiz Talk to a Product Advisor to find the best product for you! Call 1-540-299-1557 with your questions about Dr. Berg's products. Product Advisors are available Monday through Friday 8 am - 6 pm and Saturday 9 am - 5 pm EST. At this time, we no longer offer Keto Consulting and our Product Advisors will only be advising on which product is best for you and advise on how to take them. Dr. Eric Berg DC Bio: Dr. Berg, 51 years of age is a chiropractor who specializes in weight loss through nutritional & natural methods. His private practice is located in Alexandria, Virginia. His clients include senior officials in the U.S. government & the Justice Department, ambassadors, medical doctors, high-level executives of prominent corporations, scientists, engineers, professors, and other clients from all walks of life. He is the author of The 7 Principles of Fat Burning. Dr. Berg's Website: http://bit.ly/37AV0fk Dr. Berg's Recipe Ideas: http://bit.ly/37FF6QR Dr. Berg's Reviews: http://bit.ly/3hkIvbb Dr. Berg's Shop: http://bit.ly/3mJcLxg Dr. Berg's Bio: http://bit.ly/3as2cfE Dr. Berg's Health Coach Training: http://bit.ly/3as2p2q Facebook: https://www.facebook.com/drericberg Messenger: https://www.messenger.com/t/drericberg Instagram: https://www.instagram.com/drericberg/ YouTube: http://bit.ly/37DXt8C Pinterest: https://www.pinterest.com/drericberg/

The first in a two-part discussion regarding 2023 updates to the GOLD Guidelines for COPD. Drs. Kalhan and Ohar discuss what's new, what's changed, and what this means to those who see and care for patients with COPD.

Chronic Obstructive Pulmonary Disease - or COPD - is the fourth leading cause of death in New Zealand, yet very few people have ever heard of it. 

Brush up on your COPD skills and learn some new tips for diagnosis and management of this common respiratory condition from our expert Dr. Antonio Anzueto (University of Texas San Antonio).  Claim free CME for this episode at curbsiders.vcuhealth.org! Episodes | Subscribe | Spotify | Swag! | Top Picks | Mailing List | thecurbsiders@gmail.com | Free CME! Show Segments Intro, disclaimer, guest bio Guest one-liner Case from Kashlak Epidemiology Diagnosis Workup Characterization of disease Treatment Outro Credits Writer and Producer: Cyrus Askin, MD Show Notes: Deborah Gorth MD, PhD Infographic: Kate Grant MD Cover Art: Kate Grant MD Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP    Associate Editor: Leah Witt, MD Showrunner: Matthew Watto MD, FACP Technical Production: PodPaste Guest: Antonio Anzueto, MD Sponsor: Wild Grain Start your subscription at Wildgrain.com/curb and get $30 off your first box plus free croissants in every box. Sponsor: Grammarly Go to grammarly.com/curb to sign up for a free account and get 20% off when you upgrade to Grammarly Premium.

Videos : Those who speak out are shouted down until they are proved right, says Neil Oliver – 10:06 Gad Saad: Why Rational People Fall for ‘Parasitic' Ideas | American Thought Leaders CLIP – 9:11 Scientist Carl Sagan testifying to the U.S. Senate in 1985 on the greenhouse effect: – 2:44 Parent Eviscerates School Board Over Censorship– 4:59 Vitamin C supplementation associated with improved lung function in COPD Medical College of Lanzhou University (China), September 23 2022. The International Journal of Chronic Obstructive Pulmonary Disease published a systematic review and meta-analysis of clinical trials that found improvement in lung function among chronic obstructive pulmonary disease (COPD) patients who received vitamin C. The disease is characterized by airflow limitation and persistent respiratory symptoms. Ting Lei of Medical College of Lanzhou University in Lanzhou, China and associates identified 10 randomized, controlled trials that included a total of 487 adults with COPD for the meta-analysis. The trials compared lung function and/or antioxidant enzyme or nutrient levels of COPD patients who received vitamin C to a placebo or control group. The meta-analysis found improvement in forced expiratory volume in one second as a percentage (FEV1%, a measure of lung function) in association with vitamin C supplementation. When dosage was analyzed, it was determined that consuming more than 400 milligrams vitamin C per day was needed experience a significant benefit. The ratio of FEV1 to forced vital capacity (another lung function assessment), and levels of vitamin C and glutathione, both of which are antioxidants, also improved among participants who received vitamin C supplements. The authors remarked that oxidative stress, which is a disturbance of the oxidant to antioxidant balance, has been suggested as playing a role in the development of COPD. The current investigation is the first systematic review and meta-analysis to assess the effect of vitamin C supplementation in people with COPD. “We found that supplementing vitamin C to patients with COPD demonstrated vital clinical significance,” Lei and associates concluded. “Vitamin C supplementation could increase the levels of antioxidation in serum (vitamin C and glutathione) and improve lung function (FEV1% and FEV1/FVC), especially in patients treated with vitamin C supplementation greater than 400 mg/day.” Single Flavanoid (Found in 6 Foods) Reduces Cognitive Impairment Drastically Fourth Military Medical University (China), September 19, 2022 A singular flavanoid can protect the brain against cognitive deficit and other cellular damage, according to studies from the Fourth Military Medical University. The news comes from Xi'an, People's Republic of China, and shows great promise for those suffering from mental impairment due to Alzheimer's disease, vascular dementia, and other debilitating cognitive conditions. The study abstract concludes: “Our results provide new insights into the pharmacological actions of rutin and suggest that rutin has multi-targeted therapeutical potential on cognitive deficits associated with conditions with chronic cerebral hypoperfusion such as vascular dementia and Alzheimer's disease.” Rutin is a biologically active flavonoid found in the following foods:  Buckwheat – Possibly the best source of rutin, and much better than boiled oats, uncooked buckwheat leaf flower offers about 675 mg in a 1.1 cup serving. Uncooked buckwheat groats contain 230 mg of rutin per 1 kg, dark buckwheat flour has 218 mg per 1 kg and buckwheat noodles provide 78 mg. Elderflower Tea – When dried, the white flowers of the elderflower make a delicious and rutin-filled tea. According to the Czech Journal of Food Science, elderflower tea contains approximately 10.9g/kg of rutin per brewed cup. Amaranth Leaves – In Western cultures, most people are familiar with the edible seeds of amaranth, though in Chinese and Southeast Asian cooking the leaves are also gaining traction, partly due to their high rutin content. You can expect around 24.5g/kg from the dried leaves. Seeds only contain trace amounts of the important nutrient. Unpeeled Apples – Keep the peel on your apples to enjoy lots of rutin. Just be sure that they are organic, since apple peels are especially prone to pesticide build-up. Apple skins are 6x as powerful as the flesh at preventing high blood pressure due to this flavanoid, too. • Unfermented Rooibos Tea – While rooibos tea contains fewer antioxidants than black or green teas, it is a good source of rutin, providing around 1.69 mg/g. • Figs – These little gems contain about the same amount of rutin as apples, so be sure to add them to your diet. The scientists found that rutin works primarily through anti-inflammatory mechanisms, and reducing hypofusion in the brain. Resistance-breathing training found to lower blood pressure University of Colorado and University of Arizona, September 23, 2022 A team of researchers with members from the University of Colorado, the University of Arizona and Alma College, has found that resistance-breathing training can lower blood pressure as much as some medicines and/or exercises. The study is published in the Journal of Applied Physiology. Hypertension, also known as chronic high blood pressure, can lead to a wide variety of health problems, from loss of vision to strokes and heart attacks. For that reason, doctors take it seriously. Typically, patients are directed to modify their diet and to exercise more. If that does not fix the problem, medications are prescribed. In this new effort, the researchers looked into a new type of therapy to reduce blood pressure levels—resistance-breathing training. Resistance-breathing training involves breathing in and out of a small device, called, quite naturally, a POWERbreathe, every day for several minutes. The device forces the patient to use their breathing muscles to push and pull air through it, making them stronger. And that, the researchers found, also reduces blood pressure. The device has been in use for several years as a means to assist athletes, singers and people with weak lung muscles. Several groups of healthy volunteers practiced the training for a few minutes every day for six weeks. Each was breathed in and out with the device 30 times each session. Each of the volunteers had their blood pressure measured before and after the training. The researchers found a sustained average drop of 9 mmHg in systolic blood pressure (the top number in blood pressure readings)—normal pressure is defined as 120/80. They describe the change as significant, as much as some patients see with medication. They also note that it is similar to changes in many patients who begin an aerobic exercise regimen, such as walking, cycling or running. They suggest such training could be used by patients of all ages who are unable to exercise to lower their blood pressure. How To Maintain Peak Brain Health: Scientists Say It Comes Down To These 3 Factors Norwegian University of Science and Technology, September 23, 2022 What's the best way to maintain peak brain health as we age? There are countless studies detailing ways to prevent cognitive decline, so scientists in Norway sought to simplify the science of managing strong brain health to three recommendations. This report is something of a summation covering modern science's current understanding of how best to cultivate robust brain health. The team at NTNU cite 101 references to prior articles in this latest theoretical perspective paper. “Three factors stand out if you want to keep your brain at its best,” Prof. Sigmundsson adds. The three identified keys to strong brain health are: Physical exercise Social activity Strong, passionate interests and hobbies It's common knowledge that spending all day on the couch isn't healthy for the body, but physical activity is also key to brain health. “An active lifestyle helps to develop the central nervous system and to counteract the aging of the brain,” according to study authors. Researchers add that consistency is essential. Do your best to get in at least a little movement each and every day. Even if you work a sedentary job that requires lots of sitting, get moving every hour or so for just a few minutes at the very least. Some people are naturally more social than others, but researchers stress that no one is an island. Even if you prefer a quiet night in to attending a party, make an effort to stay in touch with the people who matter to you. Our brains thrive on social interactions and connections. “Relationships with other people, and interacting with them, contribute to a number of complex biological factors that can prevent the brain from slowing down,” Prof. Sigmundsson explains. Just like bicep curls help us build muscle, keeping the brain active promotes strong lifelong cognition. Consider taking up a new hobby, or learning a new skill. Perhaps most importantly, though, don't force it; find something you're actually passionate about. It's never too late in life to learn something new! “Passion, or having a strong interest in something, can be the decisive, driving factor that leads us to learn new things. Over time, this impacts the development and maintenance of our neural networks,” Prof. Sigmundsson says. “Brain development is closely linked to lifestyle. Physical exercise, relationships and passion help to develop and maintain the basic structures of our brain as we get older,” Prof. Sigmundsson concludes. Calcium supplements may support a healthy colon: Harvard study Harvard School of Public Health, September 18, 2022 Supplements of calcium or non-dairy products fortified with the mineral may reduce the risk of colorectal cancer, according to meta-analysis of prospective observational studies by researchers at Harvard School of Public Health. For every 300 mg increase in calcium from supplements was associated with a 9% reduction in risk, wrote NaNa Keum and her co-authors in the International Journal of Cancer . Every 300 mg increase in total calcium was associated with a similar reduction in risk (8%), they added. “Our findings have several important clinical and public health implications,” they explained. “First, according to the 2003 to 2006 National Health and Nutrition Examination Survey, a nationally representative cross-sectional survey in the U.S., median total calcium intake of adults aged over 50 years was approximately 650 mg/day for no calcium-supplement users and 1,000 mg/day for calcium-supplement users. “As the benefit of calcium intake on CRC is expected to continue beyond 1,000 mg/day, not only non-supplement users but also supplement users may further reduce their CRC risk through additional calcium intake.” “Second, while dairy products, especially milk, are the major sources of calcium in many countries, they are a substantial source of calories and contain potentially harmful factors such as saturated fat, hormones, and casein proteins. Since our analyses provide evidence for an equivalent benefit of dietary and supplementary calcium, the benefit of calcium on CRC risk may be obtained through supplements and non-dairy products fortified with calcium.” The Boston-based scientists conducted dose-response meta-analyses of 15 studies involving 12,305 cases of colorectal cancer and calcium intakes ranging from 250-1,900 mg/day. The studies varied in duration from 3.3 to 16 years. The data indicated that both total and supplemental calcium were associated with reductions in the risk of colorectal cancer. “In conclusion, both dietary and supplementary calcium intake may continue to decrease colorectal cancer risk beyond 1,000 mg/day,” wrote Keum and her co-authors. Yoga's Age-Defying Effects Confirmed by Science Defence Institute of Physiology and Allied Sciences (India), September 21st 2022 While yoga's longevity promoting effects have been the subject of legend for millennia, increasingly modern science is confirming this ancient technology for spiritual and physical well-being actually can slow aging and stimulate our regenerative potential. One particularly powerful study published lin the journal Age titled, “Age-related changes in cardiovascular system, autonomic functions, and levels of BDNF of healthy active males: role of yogic practice”, found that a brief yoga intervention (3 months) resulted in widespread improvements in cardiovascular and neurological function. Indian researchers studied healthy active males of three age groups (20-29, 30-39, and 40-49 years) by randomly assigning them to practice one hour of yoga daily for 3 months. The observed significant differences between the younger and older participants in the study, specifically: “Significantly higher values of heart rate (HR), blood pressure (BP), load in heart (DoP), myocardial oxygen consumption (RPP), and total cholesterol (TC) were noted in senior age group.” The yogic practice resulted in significant reductions in all of these parameters (HR, BP, DoP, RPP and TC). Also observed in the older participants were decreases in high frequency (HF), total power (TP), all time domain variables of heart rate variability (HRV), and skin conductance (SC) — all of which increased following yogic practice. Higher levels of catecholamines (“stress hormones”) and low frequency (LF) power of HRV were noted in advancement of age, both of which decreased following yogic practice. Additionally, the senior age group had highest levels of cortisol and adrenocorticotrophic hormone (ACTH), both of which decreased following yogic practice. Finally, brain-derived neurotropic factor (BDNF), serotonin, and dopamine were low in higher age group, but these increased following yogic practice; an indication of improved brain function and cognition. The researchers concluded: ‘This study revealed that yogic practices might help in the prevention of age-related degeneration by changing cardiometabolic risk factors, autonomic function, and BDNF in healthy male.” There are a number of promising studies revealing the age-defying potential of this ancient practice. Here are some additional benefits confirmed in 2014 alone: Age-Related Respiratory Problems: A 2014 study from the journal of Human Kinetics found that a 3 month yoga intervention in 36 elderly women (average age 63.1) significantly improved pulmonary (respiratory) function. Age-Related Brain Cognitive Decline: A review in the Journals of Gerontology, involving a two month Hatha yoga intervention in the elderly (average age 62.0) resulted in significant improvements in “executive function measures of working memory capacity and efficiency of mental set shifting and flexibility compared with their stretching-strengthening counterparts.” Age-Related Hormone Insufficiency: A study published in Evidence Based Complementary and Alternative Medicine found that a 3 month yogic intervention in men (average age 42.8) and women (average age 44.75) resulted in improvements in the level of growth hormone and DHEAS, two essential hormones that drop off precipitously as we age. Age-Related Sleep Problems: Astudy published in Alternatives Therapies in Health and Medicine found a 12 week yogic intervention (yoga 2x a week) resulted in significant improvements in the quality of sleep in older individuals (average age 60). Age-Related Depression: From the Chinese Journal of Nursing found that not only did yoga improve sleep as found in the study above but also significantly reduced the depressive symptoms of elderly participants…after 6 months. “ This is just a small sampling of the literature. There is older research revealing that yoga has even more benefits for aging populations.

Healthcare costs due to Chronic Obstructive Pulmonary Disease (COPD) is in excess of $32 billion due to high rates of re-hospitalizations and ED visits, complex and inefficient clinical pathways during transitions of care, and intensive resource burden on clinical and administrative staff. The average cost per COPD patient readmission in the U.S. typically falls between $9,000 and $12,000. Unlike other high cost chronic conditions like CHF and diabetes, it seems that many ACOs are not as purposeful in their targeting of COPD as part of their population health playbook. This is a massive unmet need with many COPD patients experiencing fragmented and inconsistent care that drives poor clinical outcomes and high economic burden. Consequently, COPD now represents the 3rd leading cause of death and the 5th most costly chronic disease in the US. What is it about this particular chronic condition that makes it so less prone for population health management with ACOs and other risk-bearing entities?  Why is this chronic disease so universally undiagnosed? How can we implement chronic care management programs that actually make an impact on patient lung health and clinical outcomes? For anyone that wants to know more about “Effective COPD Management to Achieve Value-Based Care Goals”, look no further than this week's episode with Dr. MeiLan Han. She is Professor and Chief of Pulmonary and Critical Care Medicine at the University of Michigan who is widely known for her expertise on Chronic Obstructive Pulmonary Disease. Dr. Han is a leading pulmonologist, researcher, lung health advocate, consultant, and national volunteer spokesperson for the American Lung Association. She is also the author of the new book, “Breathing Lessons: A Doctor's Guide to Lung Health.”   Episode Bookmarks: 01:30 Introduction to Dr. MeiLan Han (pulmonologist, COPD researcher, lung health advocate, author, and speaker) 05:30 Origins in rural, small town America that led to a career in pulmonary medicine and research 07:00 “Many people that have lung damage and don't know it. We don't do a good job of diagnosing lung disease in this country.” 07:30 Only half of the 25-30M Americans with COPD even have a diagnosis! 08:00 Undiagnosed lung disease led to server morbidity and increased mortality during COVID-19 pandemic 08:30 Research continues to be under-funded due to lack of awareness of lung health importance 09:20 11M Americans suffering from long-haul COVID 09:40 Societal threats to lung health (ex: air pollution, hazardous chemicals, plastic microparticles in lungs) 10:00 “The pandemic was a golden opportunity to raise awareness for lung health, but now people are starting not to listen.” 12:00 The impact of race and socioeconomic status on COVID death rates, and overall poor lung health in marginalized communities 13:30 COPD is more common in rural communities where there is less access to care 14:20 Virtual care is not a perfect solution in areas where there is a “digital divide” 16:00 Half of adult Americans have at least one chronic condition and more than two thirds of Medicare patients have two or more. 17:00 Ambulatory Care Sensitive Conditions as an opportunity for ACOs to achieve cost savings 18:30 The challenges of developing and implementing COPD Quality Improvement Measures 19:00 Difficulties in collecting data from spirometry and PFTs in the Electronic Medical Record 20:00 Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommendations and the difficulties of tracking symptoms and exacerbations 22:00 The lack of reporting requirements on COPD has limited progress of health systems and EHR companies 23:00 The relative ease of collecting Blood Pressure and A1c results and why capturing data related to COPD is so much more difficult 24:45 Diagnosis gaps of COPD in the early stages due to “therapeutic nihilism” 26:15 Lack of spirometry testing possibly due to the ...

Interview with Katrina E. Donahue, MD, MPH, USPSTF member and coauthor of Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Reaffirmation Recommendation Statement. Hosted by JAMA Senior Editor Kristin Walter, MD. Related Content: USPSTF Review: Screening for Chronic Obstructive Pulmonary Disease Screening for Chronic Obstructive Pulmonary Disease: Challenges and Opportunities USPSTF Recommendation: Screening for Chronic Obstructive Pulmonary Disease Patient Information: Screening for Chronic Obstructive Pulmonary Disease

The Pulm PEEPs are extremely excited today to be launching our series on Chronic Obstructive Pulmonary Disease in partnership with the ATS Clinical Problems Assembly. We are joined by Dr. Bob Wise and Dr. Wassim Labaki to discuss the classification … Continue reading →

Dr. Rountree reviews a 2018 study on laser therapy for the experimental treatment of COPD on mice. What is COPD? Chronic obstructive pulmonary disease-a progressive, debilitating life long disease. Laser therapy for COPD is not yet FDA approved. Follow along as Dr. Rountree explains the prevalence of COPD, factors that contribute to COPD, the body's natural response in the lungs, and the effect of laser therapy on the cells of the lungs. We have begun live-streaming this podcast. Watch this episode on Facebook right here, and see the next episode LIVE in two weeks!Study mentioned in this episode:Low-Level Laser Therapy Reduces Lung Inflammation in an Experimental Model of Chronic Obstructive Pulmonary Disease Involving P2X7 ReceptorVisit the LTI website for more information and to find a laser therapy provider near you.  Are you a healthcare provider?Laser Therapy Institute Podcast  YouTube ChannelHealing at the Speed of Light